ROIV
#516
Roivant Sciences Ltd. - Common Shares
34.9 1 USD
+0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.16%
Changement Mensuel
+16.25%
Evolution sur 6 mois
+52.78%
Changement Annuel
+90.66%
Clôture Précédente
34.5 1
Open
34.9 1
Low
34.9 1
High
34.9 1
Volume
264
Financials
- Market Capitalization 25.11 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 280.03 USD | -0.44% | -12.26% | -2.81% | -10.03% | 37.39 B USD | ||
| 493 |  MRNA Moderna, Inc. - Common Stock | 67.89 USD | +0.67% | -11.02% | +30.46% | +114.03% | 26.94 B USD | ||
| 520 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 55.67 USD | -1.38% | -3.75% | +2.56% | +49.41% | 24.75 B USD | ||
| 532 |  INSM Insmed Incorporated - Common Stock | 110.11 USD | +0.89% | -1.63% | +12.93% | -32.05% | 23.87 B USD |